Evidence map›Paper›PMID 33147570›Full record

ArticleAging2020

LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.

Yuxing Zhu, Hao Bo, Zhizhao Chen, Jingjing Li, Dong He, Mengqing Xiao, Liang Xiang, Long Jin, Jianda Zhou, Lian Gong and 6 more

Abstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. mHereditas · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. HNRNPA2B1-mediated mJournal of translational medicine · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Web tools to perform long non-coding RNAs analysis in oncology research.Database : the journal of biological databases and curation · 2021
    Review
  17. MicroRNAs in Metastasis and the Tumour Microenvironment.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yuxing ZhuDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Hao BoDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Zhizhao ChenDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Jingjing LiDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Dong HeDepartment of Respiration, The Second People's Hospital of Hunan Province of Hunan University of Chinese Medicine, Changsha 410000, China.
Mengqing XiaoDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Liang XiangDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Long JinDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Jianda ZhouDepartment of Plastic Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China.
Lian GongDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha 410013, China.
Yanhong ZhouCancer Research Institute and Key Laboratory of Carcinogenesis of Ministry of Health, Central South University, Changsha 410078, China.
Ming ZhouCancer Research Institute and Key Laboratory of Carcinogenesis of Ministry of Health, Central South University, Changsha 410078, China.
Wei XiongCancer Research Institute and Key Laboratory of Carcinogenesis of Ministry of Health, Central South University, Changsha 410078, China.
Xiaowei XingCenter for Medical Experiments, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Ruhong LiYan'an Affiliated Hospital of Kunming Medical University, Kunming 650051, China.
Ke CaoDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha 410013, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong non-coding RNAs (LncRNAs) have been associated with several types of cancer. However, little is known about their role in lung adenocarcinoma (LUAD).

resultsLINC00968 was significantly differentially expressed in LUAD tissues. Downregulated LINC00968 was associated with clinicopathological features of LUAD. LINC00968 inhibited cell growth and metastasis by regulating the Hippo signaling pathway We demonstrated that LINC00968 acts as a ceRNA to consume miR-21-5p, enhancing the accumulation of SMAD7, a miR-21-5p target.

conclusionsLINC00968 limits LUAD progression via the miR-21-5p/SMAD7 axis and may serve as a prognostic biomarker and therapeutic target for LUAD.

methodsWe conducted comprehensive data mining on LINC00968 based on the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) database. The expression of LINC00968 in LUAD cells was determined using

Indexed as

A549 CellsAdenocarcinoma of LungAnimalsCell MovementCell ProliferationDatabases, GeneticDisease ProgressionGene Expression Regulation, NeoplasticHumansLung NeoplasmsMaleMice, Inbred BALB CMice, NudeMicroRNAsNeoplasm InvasivenessRNA, Long NoncodingMicroRNAsMIRN21 microRNA, humanRNA, Long NoncodingSmad7 ProteinSMAD7 protein, humanLINC00968lung adenocarcinoma (LUAD)metastasisprognosisSMAD7

Identifiers

PMID33147570
PMCPMC7695398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.